We are live on ! Find out more
EBS icon

Emergent Biosolutions
EBS

140 hedge funds and large institutions have $265M invested in Emergent Biosolutions in 2024 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 30 increasing their positions, 51 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

27% more capital invested

Capital invested by funds: $208M → $265M (+$57M)

3% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 31

0.59% more ownership

Funds ownership: 58.06% → 58.66% (+0.59%)

1% less funds holding

Funds holding: 141 → 140 (-1)

11% less call options, than puts

Call options by funds: $7.37M | Put options by funds: $8.31M

41% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 51

Holders
140
Holders Change
-1
Holders Change %
-0.71%
% of All Funds
2.01%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
32
Increased
30
Reduced
51
Closed
31
Calls
$7.37M
Puts
$8.31M
Net Calls
-$935K
Net Calls Change
+$1.8M

Top Buyers

Rank Fund Capital Flow
1
Marshall Wace
Marshall Wace
United Kingdom
+$17.7M
2
State Street
State Street
Massachusetts
+$15.6M
3
OHA
Oak Hill Advisors
New York
+$10.1M
4
American Century Companies
American Century Companies
Missouri
+$7.74M
5
TI
Trexquant Investment
Connecticut
+$4M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$16.8M
2
Charles Schwab
Charles Schwab
California
-$8.56M
3
JP Morgan Chase
JP Morgan Chase
New York
-$5.9M
4
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management
California
-$5.31M
5
CCM
Carronade Capital Management
Connecticut
-$3.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
CSS
26
Cubist Systematic Strategies
Connecticut
$2.76M +$2.82M +310,760 +1,576%
Bank of America
27
Bank of America
North Carolina
$2.66M -$2.15M -236,900 -43%
Federated Hermes
28
Federated Hermes
Pennsylvania
$2.27M -$14K -1,535 -0.6%
UBS Group
29
UBS Group
Switzerland
$2.24M +$104K +11,480 +4%
Nomura Holdings
30
Nomura Holdings
Japan
$2.16M +$2.35M +258,500 New
New York State Common Retirement Fund
31
New York State Common Retirement Fund
New York
$1.81M +$713K +78,442 +57%
Squarepoint
32
Squarepoint
New York
$1.76M -$187K -20,569 -9%
KLP
33
Kent Lake PR
Puerto Rico
$1.67M +$1.82M +200,000 New
Jacobs Levy Equity Management
34
Jacobs Levy Equity Management
New Jersey
$1.55M +$1.68M +185,317 New
HH
35
Hilltop Holdings
Texas
$1.43M +$114K +12,515 +8%
Fuller & Thaler Asset Management
36
Fuller & Thaler Asset Management
California
$1.3M -$5.31M -583,930 -79%
Jane Street
37
Jane Street
New York
$1.23M -$3.12M -343,430 -70%
Truist Financial
38
Truist Financial
North Carolina
$1.2M +$115K +12,670 +10%
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.2M +$1.31M +144,021 New
Northern Trust
40
Northern Trust
Illinois
$1.19M -$2.63M -289,023 -67%
Deutsche Bank
41
Deutsche Bank
Germany
$1.16M – – –
Wellington Management Group
42
Wellington Management Group
Massachusetts
$1.14M +$203K +22,295 +20%
Fidelity Investments
43
Fidelity Investments
Massachusetts
$1.08M +$131K +14,446 +13%
SWM
44
SeaCrest Wealth Management
New York
$991K +$33.7K +3,705 +3%
BCM
45
Bridgeway Capital Management
Texas
$939K -$364K -40,000 -26%
Acadian Asset Management
46
Acadian Asset Management
Massachusetts
$853K -$57.2K -6,294 -6%
DM
47
Deerfield Management
New York
$632K +$688K +75,642 New
SG Americas Securities
48
SG Americas Securities
New York
$507K +$394K +43,378 +250%
PGCM
49
Prescott Group Capital Management
Oklahoma
$501K +$545K +60,000 New
CCIA
50
Campbell & Co Investment Adviser
Maryland
$398K +$434K +47,717 New
1
2
3 4 5

EBS Hedge Fund Activity: Q3 2024 in Review

140 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Emergent Biosolutions (EBS) for Q3 2024, worth a combined $265M — up 27% from $208M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new EBS positions and 31 closed out — a net gain of 1 holder — while 30 added to existing stakes and 51 trimmed.

The largest buyer was Marshall Wace, adding an estimated $17.7M. The largest seller was BlackRock, cutting an estimated $16.8M.

  • 140 institutional investors held Emergent Biosolutions (EBS) as of Q3 2024, down from 141 in Q2 2024.
  • Funds reported $265M of Emergent Biosolutions stock for Q3 2024, up 27% quarter-over-quarter.
  • 32 funds opened new Emergent Biosolutions positions in Q3 2024 and 31 closed out, a net change of +1 holder.
  • The largest Emergent Biosolutions buyer in Q3 2024 was Marshall Wace, an estimated $17.7M added.
  • The largest Emergent Biosolutions seller in Q3 2024 was BlackRock, an estimated $16.8M sold.

Based on aggregated 13F filings for Q3 2024.